Arcturus Therapeutics Stock Target Price and Analyst Consensus
| ARCT Stock | USD 18.05 1.64 9.99% |
The current analyst and expert consensus on Arcturus Therapeutics is Strong Buy, with 7 strong buy opinions. The current projected Arcturus Therapeutics target price consensus is 79.47 with 10 analyst opinions. Check out Macroaxis Advice on Arcturus Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Arcturus Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Arcturus Therapeutics executives and customers to further validate their buy or sell advice. Arcturus Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Arcturus Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 4.6776.
Lowest Forecast 72.32 | Highest Forecast 88.21 | Target Price 79.47 |
Arcturus |
It's important to approach Arcturus Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Arcturus Therapeutics price targets
Arcturus Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Arcturus Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Arcturus Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Arcturus Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Arcturus Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arcturus Therapeutics is a key component of Arcturus Therapeutics valuation and have some predictive power on the future returns of a Arcturus Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arcturus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Transportation Invested few shares | |
 | Macroaxis Index Invested over 90 shares | |
 | Size And Style ETFs Invested few shares | |
| Large Cap ETFs Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Driverless Cars Invested over 300 shares | |
 | Adviser Favorites Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Business Services Invested over 100 shares | |
 | Banks Invested few shares | |
Additional Tools for Arcturus Stock Analysis
When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.